{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/RNAZ/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T19:08:37.192Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2057,"canonical_name":"Transcode Therapeutics, Inc.","cik":"0001829635","uei":null,"lei":null,"duns":null,"ticker":"RNAZ"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":31},"count":31,"timeline":[{"ts":"2026-10-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-10-01","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-112826","accession_number":"0001104659-26-112826","importance":35},{"ts":"2026-09-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-09-28","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-111170","accession_number":"0001104659-26-111170","importance":35},{"ts":"2026-09-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-09-11","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-107115","accession_number":"0001104659-26-107115","importance":35},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — Transcode Therapeutics, Inc. — 2026-09-11","url_slug":"/sec/cik-0001829635/4/0001104659-26-107120","accession_number":"0001104659-26-107120","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Transcode Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001829635/10-q/0001829635-26-000003","accession_number":"0001829635-26-000003","importance":45},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-089805","accession_number":"0001104659-26-089805","importance":35},{"ts":"2026-08-03","kind":"sec.insider.c","reporter":"DEFJ, LLC","title":"","shares":11813859,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-03","kind":"sec.insider.c","reporter":"CK Life Sciences Intl (Holdings) Inc","title":"","shares":11813859,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-03","kind":"sec.insider.c","reporter":"DEFJ, LLC","title":"","shares":2020582,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-03","kind":"sec.insider.c","reporter":"CK Life Sciences Intl (Holdings) Inc","title":"","shares":2020582,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-28","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Transcode Therapeutics, Inc. — 2026-07-28","url_slug":"/sec/cik-0001829635/schedule-13g/0001493152-26-035074","accession_number":"0001493152-26-035074","importance":55},{"ts":"2026-07-28","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Transcode Therapeutics, Inc. — 2026-07-28","url_slug":"/sec/cik-0001829635/schedule-13g/0001493152-26-035075","accession_number":"0001493152-26-035075","importance":55},{"ts":"2026-07-20","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-07-20","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-085073","accession_number":"0001104659-26-085073","importance":35},{"ts":"2026-07-20","kind":"sec.filing","form_type":"424B3","title":"424B3 — Transcode Therapeutics, Inc. — 2026-07-20","url_slug":"/sec/cik-0001829635/424b3/0001104659-26-085105","accession_number":"0001104659-26-085105","importance":30},{"ts":"2026-07-20","kind":"sec.filing","form_type":"424B3","title":"424B3 — Transcode Therapeutics, Inc. — 2026-07-20","url_slug":"/sec/cik-0001829635/424b3/0001104659-26-085107","accession_number":"0001104659-26-085107","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-084617","accession_number":"0001104659-26-084617","importance":35},{"ts":"2026-07-17","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Transcode Therapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001829635/defa14a/0001104659-26-084628","accession_number":"0001104659-26-084628","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-080311","accession_number":"0001104659-26-080311","importance":35},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-075440","accession_number":"0001104659-26-075440","importance":35},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-069810","accession_number":"0001104659-26-069810","importance":35},{"ts":"2026-06-02","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Transcode Therapeutics, Inc. — 2026-06-02","url_slug":"/sec/cik-0001829635/def-14a/0001104659-26-069458","accession_number":"0001104659-26-069458","importance":40},{"ts":"2026-06-02","kind":"sec.filing","form_type":"ARS","title":"ARS — Transcode Therapeutics, Inc. — 2026-06-02","url_slug":"/sec/cik-0001829635/ars/0001104659-26-069488","accession_number":"0001104659-26-069488","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Transcode Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001829635/8-k/0001104659-26-068647","accession_number":"0001104659-26-068647","importance":35},{"ts":"2026-05-19","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Transcode Therapeutics, Inc. — 2026-05-19","url_slug":"/sec/cik-0001829635/effect/9999999995-26-001703","accession_number":"9999999995-26-001703","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Transcode Therapeutics, Inc. — 2026-05-19","url_slug":"/sec/cik-0001829635/effect/9999999995-26-001704","accession_number":"9999999995-26-001704","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Transcode Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001829635/10-q/0001104659-26-062535","accession_number":"0001104659-26-062535","importance":45},{"ts":"2026-05-15","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Transcode Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001829635/corresp/0001104659-26-062701","accession_number":"0001104659-26-062701","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Transcode Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001829635/corresp/0001104659-26-062704","accession_number":"0001104659-26-062704","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Transcode Therapeutics, Inc. — 2026-05-08","url_slug":"/sec/cik-0001829635/pre-14a/0001104659-26-058043","accession_number":"0001104659-26-058043","importance":30},{"ts":"2026-05-06","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Transcode Therapeutics, Inc. — 2026-05-06","url_slug":"/sec/cik-0001829635/upload/0000000000-26-004639","accession_number":"0000000000-26-004639","importance":30},{"ts":"2026-05-06","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Transcode Therapeutics, Inc. — 2026-05-06","url_slug":"/sec/cik-0001829635/upload/0000000000-26-004640","accession_number":"0000000000-26-004640","importance":30}]}